Study sheds new light on asthma, chronic obstructive pulmonary disease

In diseases such as asthma and chronic obstructive pulmonary disease (COPD), the body produces too much mucus, making breathing difficult. New research from Washington University School of Medicine in St. Louis provides clues to potentially counteract inappropriate mucus production.....

Read more here: sciguru.org

------------------------------------------------------

GSK, Theravance’s Breo Faces Scrutiny Over Safety for Asthma

(Bloomberg) -- GlaxoSmithKline Plc and Theravance Inc.’s respiratory drug Breo Ellipta will face questions from a regulatory panel over the safety of expanding its use to treat asthma patients and whether it’s suitable for children.....

Read more here: bloomberg.com

------------------------------------------------------

FDA staff finds no new safety problems with Glaxo's asthma drug

(Reuters) - GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems while being tested to treat asthma, a preliminary review by U.S. Food and Drug Administration staff found.....

Read more here: reuters.com